Stryker Corporation
SYK
株式のランク
#196
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
株価
$298.26
時価総額
$114.40B
変化（1日）
1.39%
変化（1年）
-20.34%
国
US
取引 Stryker Corporation (SYK)
カテゴリー
Healthcare
Stryker Corporation（SYK）の営業利益率
October 2026 時点の営業利益率 TTM: 22.03%
Stryker Corporation の最新の財務報告と株価によると、現在の営業利益率（TTM）は 22.03% です。2024 年末時点では 22.40% でした。
Stryker Corporation の営業利益率の履歴（2000 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 22.03% | -1.65% |
| 2025 | 22.40% | 0.00% |
| 2024 | 22.40% | 7.28% |
| 2023 | 20.88% | 3.16% |
| 2022 | 20.24% | -8.00% |
| 2021 | 22.00% | 4.27% |
| 2020 | 21.10% | -7.29% |
| 2019 | 22.76% | -0.26% |
| 2018 | 22.82% | 2.61% |
| 2017 | 22.24% | -2.24% |
| 2016 | 22.75% | 0.49% |
| 2015 | 22.64% | -1.74% |
| 2014 | 23.04% | -0.99% |
| 2013 | 23.27% | 5.10% |
| 2012 | 22.14% | -6.70% |
| 2011 | 23.73% | -6.13% |
| 2010 | 25.28% | -1.40% |
| 2009 | 25.64% | 10.85% |
| 2008 | 23.13% | 4.57% |
| 2007 | 22.12% | 6.09% |
| 2006 | 20.85% | 5.14% |
| 2005 | 19.83% | 0.46% |
| 2004 | 19.74% | 5.17% |
| 2003 | 18.77% | 3.25% |
| 2002 | 18.18% | 0.22% |
| 2001 | 18.14% | 15.98% |
| 2000 | 15.64% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 17.03% | -99.23% |
US
|
|
| 17.86% | -99.19% |
IE
|
|
| 21.46% | -99.03% |
US
|
|
| 0.00% | - |
DE
|
|
| 28.09% | -98.72% |
US
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。